CVA Family Office’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,007
| Closed | -$78.5K | – | 1277 |
|
|
2024
Q2 | $78.5K | Hold |
1,007
| – | – | 0.01% | 399 |
|
|
2024
Q1 | $68.2K | Sell |
1,007
-212
| -17% | -$14.4K | 0.01% | 428 |
|
|
2023
Q4 | $82.1K | Buy |
+1,219
| New | +$82.1K | 0.02% | 367 |
|
|
2023
Q3 | – | Sell |
-1,219
| Closed | -$87.2K | – | 291 |
|
|
2023
Q2 | $87.2K | Hold |
1,219
| – | – | 0.02% | 329 |
|
|
2023
Q1 | $84.6K | Sell |
1,219
-171
| -12% | -$11.9K | 0.02% | 338 |
|
|
2022
Q4 | $94.2K | Buy |
1,390
+171
| +14% | +$11.6K | 0.02% | 298 |
|
|
2022
Q3 | $67K | Hold |
1,219
| – | – | 0.02% | 301 |
|
|
2022
Q2 | $81K | Hold |
1,219
| – | – | 0.02% | 274 |
|
|
2022
Q1 | $81K | Hold |
1,219
| – | – | 0.02% | 296 |
|
|
2021
Q4 | $71K | Buy |
+1,219
| New | +$71K | 0.02% | 300 |
|
|
2021
Q3 | – | Sell |
-1,007
| Closed | -$60K | – | 409 |
|
|
2021
Q2 | $60K | Buy |
+1,007
| New | +$60K | 0.02% | 336 |
|